Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1990-08-30
1992-04-28
Robinson, Allen J.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
435 10, 435 11, 435 14, 435 25, 435 28, 514270, 514312, 514376, 514404, 514566, 514709, 514731, 514732, G01N 3315, C12Q 128, C12Q 162
Patent
active
051087332
ABSTRACT:
Spontaneous aspecific coloration in so-called Trinder reagents which can alter subsequent colorimetric determinations is inhibited by adding compounds of the chelating agent class to the solution. The resultant compositions contain a peroxidase enzyme, a phenylpyrazone derivative, a compound of phenolic or aromatic amine structure and a stabilizer. Preferred stabilizers are ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA).
REFERENCES:
patent: Re29498 (1977-12-01), Meiattini
patent: 3992158 (1976-11-01), Przybylowicz et al.
patent: 4716110 (1987-12-01), Wada et al.
Putz, G. R. et al., Am. J. Med. Technology 42(10):351-6 (1976).
Ziebig, R. et al., Zentrabl. Pharm. Pharmakother. Laboratoriumsdiagn. 125(4):223-8 (1986).
D'Alterio Maurizio
Frontini Dario
501 Instrumentation Laboratory S.p.A.
Hollinden Gary E.
Instrumentation Laboratory S.p.A.
Robinson Allen J.
LandOfFree
Stabilized Trinder reagent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Stabilized Trinder reagent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Stabilized Trinder reagent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1247493